Scientists have used a new gene-editing technology called CRISPR, to repair a genetic mutation responsible for vision loss in patient-derived stem cells.
Columbia researchers have developed a method to generate hypothalamic-like neurons from human pluripotent stem cells, which could aid the study of obesity.
A stem cell capable of regenerating both bone and cartilage has been identified in bone marrow of mice.
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.
Personalized stem cell transplants for age-related macular degeneration may reach clinical trials soon.